Browsing Tag
VYVGART Hytrulo
2 posts
VYVGART Sjögren’s setback sends argenx shares lower despite $1.5bn quarterly sales
argenx shares sink after the Phase 3 UNITY failure removes a major VYVGART expansion opportunity despite continued blockbuster sales growth.
FDA approves Halozyme’s VYVGART Hytrulo for CIDP treatment
Halozyme Therapeutics, Inc. (NASDAQ: HALO) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA)…